CVS HEALTH CVS
單位：USD
66.84
-0.25
(-0.37%)
單位：美金千元
| 科目 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | 2023/Q2 | 2023/Q1 | 2022/Q4 | 2022/Q3 | 2022/Q2 | 2022/Q1 | 2021/Q4 | 2021/Q3 | 2021/Q2 | 2021/Q1 | 2020/Q4 | 2020/Q3 | 2020/Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
營業收入淨額
| 94,588,000 | 97,710,000 | 95,428,000 | 91,234,000 | 88,437,000 | 93,813,000 | 89,764,000 | 88,921,000 | 85,278,000 | 83,846,000 | 81,159,000 | 80,636,000 | 76,826,000 | 76,604,000 | 73,794,000 | 72,616,000 | 69,097,000 | 69,554,000 | 67,056,000 | 65,341,000 |
營業成本
| 51,057,000 | 55,268,000 | 52,948,000 | 49,998,000 | 48,073,000 | 57,419,000 | 54,688,000 | 53,536,000 | 71,903,000 | 123,009,000 | 103,341,000 | 66,924,000 | 63,460,000 | 62,952,000 | 61,092,000 | 59,421,000 | 56,598,000 | 57,597,000 | 55,336,000 | 51,993,000 |
營業毛利
| 43,531,000 | 42,442,000 | 42,480,000 | 41,236,000 | 40,364,000 | 36,394,000 | 35,076,000 | 35,385,000 | 13,375,000 | -39,163,000 | -22,182,000 | 13,712,000 | 13,366,000 | 13,652,000 | 12,702,000 | 13,195,000 | 12,499,000 | 11,957,000 | 11,720,000 | 13,348,000 |
營業費用
| 40,157,000 | 40,074,000 | 41,648,000 | 38,191,000 | 38,093,000 | 33,021,000 | 31,386,000 | 32,151,000 | 9,580,000 | -42,626,000 | -20,576,000 | 9,239,000 | 9,876,000 | 11,423,000 | 9,641,000 | 8,869,000 | 8,922,000 | 9,433,000 | 8,471,000 | 8,668,000 |
研發費用
| - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
推銷及管理費用
| 40,157,000 | 39,964,000 | 40,479,000 | 38,191,000 | 38,093,000 | 33,021,000 | 31,375,000 | 31,655,000 | 9,580,000 | -42,725,000 | -25,796,000 | 9,723,000 | 9,876,000 | 10,065,000 | 9,210,000 | 8,869,000 | 8,922,000 | 9,433,000 | 8,471,000 | 8,668,000 |
非經常性項目費用
| - | 110,000 | 1,169,000 | - | - | - | 11,000 | 496,000 | - | 99,000 | 5,220,000 | -484,000 | - | 1,358,000 | 431,000 | - | - | - | - | - |
其他營業費用
| - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
營業利益
| 3,374,000 | 2,368,000 | 832,000 | 3,045,000 | 2,271,000 | 3,373,000 | 3,690,000 | 3,234,000 | 3,446,000 | 3,451,000 | -4,086,000 | 4,514,000 | 3,490,000 | 2,229,000 | 3,061,000 | 4,326,000 | 3,577,000 | 2,524,000 | 3,249,000 | 4,680,000 |
其他收入及費用
| 28,000 | 516,000 | 25,000 | 24,000 | 25,000 | 22,000 | 22,000 | 22,000 | -327,000 | 31,000 | -2,439,000 | 84,000 | 42,000 | -51,000 | -314,000 | 45,000 | 50,000 | -621,000 | -712,000 | 45,000 |
利息費用
| 785,000 | 758,000 | 752,000 | 732,000 | 716,000 | 690,000 | 693,000 | 686,000 | 589,000 | 552,000 | 566,000 | 583,000 | 586,000 | 608,000 | 602,000 | 636,000 | 657,000 | 678,000 | 731,000 | 765,000 |
稅前純益
| 2,617,000 | 2,126,000 | 105,000 | 2,337,000 | 1,580,000 | 2,705,000 | 3,019,000 | 2,570,000 | 2,879,000 | 2,942,000 | -4,611,000 | 3,974,000 | 2,946,000 | 1,570,000 | 2,145,000 | 3,735,000 | 2,970,000 | 1,225,000 | 1,806,000 | 3,960,000 |
所得稅
| 835,000 | 503,000 | 34,000 | 569,000 | 456,000 | 658,000 | 754,000 | 656,000 | 737,000 | 772,000 | -1,082,000 | 1,055,000 | 633,000 | 274,000 | 558,000 | 944,000 | 746,000 | 241,000 | 587,000 | 974,000 |
稅後純益
| 1,779,000 | 1,644,000 | 87,000 | 1,770,000 | 1,113,000 | 2,046,000 | 2,261,000 | 1,901,000 | 2,136,000 | 2,172,000 | -3,536,000 | 2,909,000 | 2,312,000 | 1,306,000 | 1,598,000 | 2,783,000 | 2,223,000 | 973,000 | 1,224,000 | 2,975,000 |
基本每股稅後盈餘(元)
| 1.41 | 1.31 | 0.07 | 1.41 | 0.88 | 1.59 | 1.76 | 1.48 | 1.66 | 1.76 | -2.59 | 2.31 | 1.79 | 0.99 | 1.21 | 2.11 | 1.69 | 0.74 | 0.93 | 2.27 |
稀釋每股稅後盈餘(元)
| 1.41 | 1.31 | 0.07 | 1.4 | 0.88 | 1.59 | 1.75 | 1.48 | 1.65 | 1.77 | -2.57 | 2.29 | 1.77 | 1.04 | 1.2 | 2.1 | 1.68 | 0.74 | 0.93 | 2.26 |
基本平均股數(千股)
| 1,261,000 | 1,259,000 | 1,259,000 | 1,256,000 | 1,260,000 | 1,288,000 | 1,287,000 | 1,283,000 | 1,283,000 | 1,310,000 | 1,315,000 | 1,313,000 | 1,312,000 | 1,322,000 | 1,321,000 | 1,319,000 | 1,313,000 | 1,311,000 | 1,310,000 | 1,309,000 |
稀釋平均股數(千股)
| 1,264,000 | 1,261,000 | 1,259,000 | 1,259,000 | 1,267,000 | 1,293,000 | 1,290,000 | 1,287,000 | 1,291,000 | 1,319,000 | 1,315,000 | 1,321,000 | 1,328,000 | 1,336,000 | 1,329,000 | 1,327,000 | 1,322,000 | 1,317,000 | 1,315,000 | 1,314,000 |
還原基本每股稅後盈餘(元)
| 1.41 | 1.31 | 0.07 | 1.41 | 0.88 | 1.59 | 1.76 | 1.48 | 1.66 | 1.76 | -2.59 | 2.31 | 1.79 | 0.99 | 1.21 | 2.11 | 1.69 | 0.74 | 0.93 | 2.27 |
還原稀釋每股稅後盈餘(元)
| 1.41 | 1.31 | 0.07 | 1.4 | 0.88 | 1.59 | 1.75 | 1.48 | 1.65 | 1.77 | -2.57 | 2.29 | 1.77 | 1.04 | 1.2 | 2.1 | 1.68 | 0.74 | 0.93 | 2.26 |
還原基本平均股數(千股)
| 1,261,000 | 1,259,000 | 1,259,000 | 1,256,000 | 1,260,000 | 1,288,000 | 1,287,000 | 1,283,000 | 1,283,000 | 1,310,000 | 1,315,000 | 1,313,000 | 1,312,000 | 1,322,000 | 1,321,000 | 1,319,000 | 1,313,000 | 1,311,000 | 1,310,000 | 1,309,000 |
還原稀釋平均股數(千股)
| 1,264,000 | 1,261,000 | 1,259,000 | 1,259,000 | 1,267,000 | 1,293,000 | 1,290,000 | 1,287,000 | 1,291,000 | 1,319,000 | 1,315,000 | 1,321,000 | 1,328,000 | 1,336,000 | 1,329,000 | 1,327,000 | 1,322,000 | 1,317,000 | 1,315,000 | 1,314,000 |
EBITDA(千元)
| 4,553,000 | 4,052,000 | 2,034,000 | 4,222,000 | 3,423,000 | 4,528,000 | 4,835,000 | 4,347,000 | 4,463,000 | 4,562,000 | -2,985,000 | 5,640,000 | 4,586,000 | 3,303,000 | 3,892,000 | 5,500,000 | 4,752,000 | 3,031,000 | 3,656,000 | 5,816,000 |
